Search research articles
Contact Us
Filters
Showing results (251-260 of 260) with videos related to
Page
of 26
Sort By:
You have reached the last page of results.
This site can display upto 260 results.
Bone Marrow Transplantation
|
September 29, 2009
Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)
S A Mitchell, N Kline Leidy, K H Mooney, et al.
HGG Advances
|
January 20, 2022
Erratum: Orofacial overgrowth with peripheral nerve enlargement and perineuriomatous pseudo-onion bulb proliferations is part of the <i>PIK3CA</i>-related overgrowth spectrum
Ioannis G Koutlas, Ana-Lia Anbinder, Rana Alshagroud, et al.
Journal of Medicinal Chemistry
|
March 10, 2020
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases
Scott J Hecker, K Raja Reddy, Olga Lomovskaya, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 14, 2007
Quinazolinone fungal efflux pump inhibitors. Part 3: (N-methyl)piperazine variants and pharmacokinetic optimization
William J Watkins, Lee Chong, Aesop Cho, et al.
Journal of Medicinal Chemistry
|
March 18, 2015
Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases
Scott J Hecker, K Raja Reddy, Maxim Totrov, et al.
Journal of Medical Genetics
|
March 8, 2019
<i>NAA10</i> polyadenylation signal variants cause syndromic microphthalmia
Jennifer J Johnston, Kathleen A Williamson, Christopher M Chou, et al.
JAMA
|
February 28, 2018
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial
Keith S Kaye, Tanaya Bhowmick, Symeon Metallidis, et al.
Infectious Diseases and Therapy
|
October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Richard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
Nature Communications
|
March 26, 2022
A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens
Kade D Roberts, Yan Zhu, Mohammad A K Azad, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 27, 2021
Somatic PIK3R1 variation as a cause of vascular malformations and overgrowth
Catherine E Cottrell, Nicole R Bender, Michael T Zimmermann, et al.
Page
of 26
Search research articles
Search
Showing results (251-260 of 260) with videos related to
Sort By:
Page
of 26
You have reached the last page of results.
This site can display upto 260 results.
Bone Marrow Transplantation
|
September 29, 2009
Determinants of functional performance in long-term survivors of allogeneic hematopoietic stem cell transplantation with chronic graft-versus-host disease (cGVHD)
S A Mitchell, N Kline Leidy, K H Mooney, et al.
HGG Advances
|
January 20, 2022
Erratum: Orofacial overgrowth with peripheral nerve enlargement and perineuriomatous pseudo-onion bulb proliferations is part of the <i>PIK3CA</i>-related overgrowth spectrum
Ioannis G Koutlas, Ana-Lia Anbinder, Rana Alshagroud, et al.
Journal of Medicinal Chemistry
|
March 10, 2020
Discovery of Cyclic Boronic Acid QPX7728, an Ultrabroad-Spectrum Inhibitor of Serine and Metallo-β-lactamases
Scott J Hecker, K Raja Reddy, Olga Lomovskaya, et al.
Bioorganic & Medicinal Chemistry Letters
|
March 14, 2007
Quinazolinone fungal efflux pump inhibitors. Part 3: (N-methyl)piperazine variants and pharmacokinetic optimization
William J Watkins, Lee Chong, Aesop Cho, et al.
Journal of Medicinal Chemistry
|
March 18, 2015
Discovery of a Cyclic Boronic Acid β-Lactamase Inhibitor (RPX7009) with Utility vs Class A Serine Carbapenemases
Scott J Hecker, K Raja Reddy, Maxim Totrov, et al.
Journal of Medical Genetics
|
March 8, 2019
<i>NAA10</i> polyadenylation signal variants cause syndromic microphthalmia
Jennifer J Johnston, Kathleen A Williamson, Christopher M Chou, et al.
JAMA
|
February 28, 2018
Effect of Meropenem-Vaborbactam vs Piperacillin-Tazobactam on Clinical Cure or Improvement and Microbial Eradication in Complicated Urinary Tract Infection: The TANGO I Randomized Clinical Trial
Keith S Kaye, Tanaya Bhowmick, Symeon Metallidis, et al.
Infectious Diseases and Therapy
|
October 2, 2018
Effect and Safety of Meropenem-Vaborbactam versus Best-Available Therapy in Patients with Carbapenem-Resistant Enterobacteriaceae Infections: The TANGO II Randomized Clinical Trial
Richard G Wunderink, Evangelos J Giamarellos-Bourboulis, Galia Rahav, et al.
Nature Communications
|
March 26, 2022
A synthetic lipopeptide targeting top-priority multidrug-resistant Gram-negative pathogens
Kade D Roberts, Yan Zhu, Mohammad A K Azad, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
May 27, 2021
Somatic PIK3R1 variation as a cause of vascular malformations and overgrowth
Catherine E Cottrell, Nicole R Bender, Michael T Zimmermann, et al.
Page
of 26